Fast-growing EBITDA-profitable next-gen aesthetic/medical laser co., seeks growth capital to replicate proven model/success over wider geographic footprint.
We are inventor and sole provider of portable high power/efficacious lasers for dermatology, aesthetics, woundhealing, other. >600 lasers sold in US. Vertically integrated: self-manufacture, 12 person salesforce in US. Has a unique strongly patent-protected de novo technology platform which provides many dramatic advantages over all competition. Financial Plan: 2015 revs. $9.6M/EBITDA $1.8M; 2016 and 2017: $20M/$5M and $60M/$20M, respectively..